Study type: In vitro · Status: Verified against declared source

Thymosin β-4 is a novel regulator for primary cilium formation by nephronophthisis 3 in HeLa human cervical cancer cells.

Scientific reports · 2019

Study scale: Thymosinβ-4(Tβ4) is an actin-sequestering protein involved in tumor malignancy.

Abstract only: Open source record

Product or molecular entity relationships

Thymosin Beta-4 (TB500): Exact entity relationship. Legacy citation custody associates this source with the catalog record; no product-relevance conclusion is implied.

Plain-language verified summary

Question

Not reported in the reviewed source.

Methods

Not reported in the reviewed source.

Scale or participants

Thymosinβ-4(Tβ4) is an actin-sequestering protein involved in tumor malignancy.

Key findings

Thymosinβ-4(Tβ4) is an actin-sequestering protein involved in tumor malignancy.

Limitations and uncertainty

Not reported in the reviewed source.

Verified against declared source. Verification is limited to the declared source and review scope. It does not mean independent replication or establish efficacy, safety, or suitability.